Annual EBITDA
-$18.28 M
-$3.48 M-23.55%
31 December 2023
Summary:
PaxMedica Common Stock annual earnings before interest, taxes, depreciation & amortization is currently -$18.28 million, with the most recent change of -$3.48 million (-23.55%) on 31 December 2023. During the last 3 years, it has fallen by -$11.06 million (-153.32%). PXMD annual EBITDA is now -2953.89% below its all-time high of -$598.60 thousand, reached on 01 December 2019.PXMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$3.00 M
+$695.40 K+18.83%
01 June 2024
Summary:
PaxMedica Common Stock quarterly earnings before interest, taxes, depreciation & amortization is currently -$3.00 million, with the most recent change of +$695.40 thousand (+18.83%) on 01 June 2024. Over the past year, it has increased by +$2.05 million (+40.61%). PXMD quarterly EBITDA is now -148.09% below its all-time high of $6.23 million, reached on 01 December 2021.PXMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$17.66 M
+$484.60 K+2.67%
01 June 2024
Summary:
PaxMedica Common Stock TTM earnings before interest, taxes, depreciation & amortization is currently -$17.66 million, with the most recent change of +$484.60 thousand (+2.67%) on 01 June 2024. Over the past year, it has dropped by -$82.60 thousand (-0.47%). PXMD TTM EBITDA is now -452.82% below its all-time high of $5.01 million, reached on 01 June 2022.PXMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PXMD EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.6% | +40.6% | -0.5% |
| 3 y3 years | -153.3% | +3.6% | -1.3% |
| 5 y5 years | - | -2073.9% | -6899.4% |
PXMD EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -153.3% | at low | -148.1% | +73.8% | -452.8% | +26.4% |
| 5 y | 5 years | -2953.9% | at low | -148.1% | +73.8% | -452.8% | +26.4% |
| alltime | all time | -2953.9% | at low | -148.1% | +73.8% | -452.8% | +26.4% |
PaxMedica Common Stock EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$3.00 M(-18.8%) | -$17.66 M(-2.7%) |
| Mar 2024 | - | -$3.69 M(-37.6%) | -$18.14 M(-0.7%) |
| Dec 2023 | -$18.28 M(+23.5%) | -$5.92 M(+17.3%) | -$18.28 M(+4.0%) |
| Sept 2023 | - | -$5.05 M(+45.0%) | -$17.58 M(-26.7%) |
| June 2023 | - | -$3.48 M(-9.1%) | -$23.99 M(+17.1%) |
| Mar 2023 | - | -$3.83 M(-26.6%) | -$20.49 M(+38.5%) |
| Dec 2022 | -$14.80 M(+99.3%) | -$5.22 M(-54.5%) | -$14.80 M(+342.1%) |
| Sept 2022 | - | -$11.46 M(<-9900.0%) | -$3.35 M(-166.9%) |
| June 2022 | - | $19.00 K(-99.0%) | $5.01 M(-537.1%) |
| Mar 2022 | - | $1.86 M(-70.1%) | -$1.15 M(-84.6%) |
| Dec 2021 | -$7.42 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $6.23 M(-300.4%) | -$7.42 M(-57.4%) |
| Sept 2021 | - | -$3.11 M(-49.3%) | -$17.43 M(+9.2%) |
| June 2021 | - | -$6.13 M(+38.9%) | -$15.96 M(+40.5%) |
| Mar 2021 | - | -$4.41 M(+17.0%) | -$11.36 M(+57.4%) |
| Dec 2020 | -$7.22 M(+1105.6%) | -$3.77 M(+129.9%) | -$7.22 M(+109.6%) |
| Sept 2020 | - | -$1.64 M(+7.5%) | -$3.44 M(+91.1%) |
| June 2020 | - | -$1.53 M(+454.8%) | -$1.80 M(+336.2%) |
| Mar 2020 | - | -$275.20 K(+99.6%) | -$413.10 K(+63.7%) |
| Dec 2019 | -$598.60 K | - | - |
| June 2019 | - | -$137.90 K(+20.5%) | -$252.30 K(+120.5%) |
| Mar 2019 | - | -$114.40 K | -$114.40 K |
FAQ
- What is PaxMedica Common Stock annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for PaxMedica Common Stock?
- What is PaxMedica Common Stock annual EBITDA year-on-year change?
- What is PaxMedica Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for PaxMedica Common Stock?
- What is PaxMedica Common Stock quarterly EBITDA year-on-year change?
- What is PaxMedica Common Stock TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for PaxMedica Common Stock?
- What is PaxMedica Common Stock TTM EBITDA year-on-year change?
What is PaxMedica Common Stock annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PXMD is -$18.28 M
What is the all time high annual EBITDA for PaxMedica Common Stock?
PaxMedica Common Stock all-time high annual earnings before interest, taxes, depreciation & amortization is -$598.60 K
What is PaxMedica Common Stock annual EBITDA year-on-year change?
Over the past year, PXMD annual earnings before interest, taxes, depreciation & amortization has changed by -$3.48 M (-23.55%)
What is PaxMedica Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PXMD is -$3.00 M
What is the all time high quarterly EBITDA for PaxMedica Common Stock?
PaxMedica Common Stock all-time high quarterly earnings before interest, taxes, depreciation & amortization is $6.23 M
What is PaxMedica Common Stock quarterly EBITDA year-on-year change?
Over the past year, PXMD quarterly earnings before interest, taxes, depreciation & amortization has changed by +$2.05 M (+40.61%)
What is PaxMedica Common Stock TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PXMD is -$17.66 M
What is the all time high TTM EBITDA for PaxMedica Common Stock?
PaxMedica Common Stock all-time high TTM earnings before interest, taxes, depreciation & amortization is $5.01 M
What is PaxMedica Common Stock TTM EBITDA year-on-year change?
Over the past year, PXMD TTM earnings before interest, taxes, depreciation & amortization has changed by -$82.60 K (-0.47%)